Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium

Scandinavian Cardiovascular Journal

Volumn 41, Issue 2, 2007, Pages 95-101

  Liu, Xiang ^a   Chen, Yijiang ^a   Zhang, Fumin ^a   Chen, Lizhen ^b   Ha, Tuanzhu ^c   Gao, Xiang ^b   Li, Chuanfu ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c East Tennessee State University   (United States)

Author keywords

Angiopoietin 1; Cardiac regeneration; Gene therapy; Myocardial infarction; VEGF165

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; BROXURIDINE; ENHANCED GREEN FLUORESCENT PROTEIN; EOSIN; HEMATOXYLIN; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DRUG POTENTIATION; GENE EXPRESSION; GENE THERAPY; HEART BLOOD VESSEL; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; M MODE ECHOCARDIOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANGIOPOIETIN-1; ANIMALS; BLOTTING, WESTERN; GENE THERAPY; HEART; MALE; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247262163     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701197593     Document Type: Article

References (24)

1. Eriksson, A., Cao, R., Roy, J., Tritsaris, K., Wahlestedt, C. and Dissing, S. (2003) Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation., 107, pp. 1532-1538.
2. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, TN and Yancopoulos, GD (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science., 286, pp. 2511-2514.
3. Thurston, G. (2002) Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat., 200, pp. 575-580.
4. Zhou, L., Yang, Z., Zhang, F. and Ding, Z. (2005) VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther, 12, pp. 196-202.
5. Ferrarini, M., Arsic, N., Recchia, FA, Zentilin, L. and Zacchigna, S. (2006) Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res, 98, pp. 954-961.
6. Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G. and Salvi, A. (2003) Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther., 7, pp. 450-459.
7. Shyu, KG, Chang, H. and Isner, J M. (2003) Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci., 73, pp. 563-579.
8. Kim, I., Moon, SO, Park, SK, Chae, SW and Koh, GY. (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res., 89, pp. 477-479.
9. Papapetropoulos, A., Fulton, D., Mahboubi, K., Kalb, RG and O'Connor, DS (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/ surviving pathway. J Biol Chem., 275, pp. 9102-9105.
10. Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S. and Yurugi, T. (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitor. Nature., 408, pp. 92-96.
11. Rabbany, SY, Heissig, B., Hattori, K. and Rafii, S. (2003) Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revasculariation. Trends Mol Med., 9, pp. 109-117.
12. Orlic, D. (2003) Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci., 996, pp. 152-157.
13. Hierlihy, AM, Seale, P., Lobe, CG, Rudnicki, MA and Megeney, L A. (2002) The post-natal heart contains a myocardial stem cell population. FEBS Lett., 530, pp. 239-243.
14. Asahara, T., Murohara, T., Sullivan, A., Silver, M. and van der Zee, R. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science., 275, pp. 964-967.
15. Ziegler, BL, Valtieri, M., Porada, GA, De Maria, R., Muller, R. and Masella, B. (1999) KDR receptor: A key marker defining hematopoietic stem cells. Science., 285, pp. 1553-1558.
16. Yuasa, H., Takakura, N., Shimomura, T., Suenobu, S., Yamada, T. and Nagayama, H. (2002) Analysis of human TIE2 function on hematopoietic stem cells in umbilical cord blood. Biochem Biophys Res Commun., 298, pp. 731-737.
17. Moore, MA, Hattori, K., Heissig, B., Shieh, JH, Dias, S. and Crystal, RG (2001) Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and Angiopoietin-1. Ann NY Acad Sci, 938, pp. 36-45.
18. Hattori, K., Dias, S., Heissig, B., Hackett, NR, Lyden, D. and Tateno, M. (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med., 193, pp. 1005-1014.
19. Orlic, D., Kajstura, J., Chimenti, S., Bodine, DM, Leri, A. and Anversa, P. (2003) Bone marrow cells regenerate infracted myocardium. Pediatr Transplant., 7, pp. 86-88.
20. Deb, A., Wang, S., Skelding, KA, Miller, D., Simper, D. and Caplice, N M. (2003) Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation., 107, pp. 1247-1249.
21. Beltrami, AP, Urbanek, K., Kajstura, J., Yan, SM, Finato, N. and Bussani, R. (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med., 344, pp. 1750-1757.
22. Duan, HF, Wu, CT, Wu, DL, Liu, HJ and Ha, XQ (2003) Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther., 8, pp. 467-474.
23. Mangi, AA, Noiseux, N., Kong, D., Rezvani, M. and Ingwall, JS (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts. Nat Med, 9, pp. 1195-1201.
24. Stewart, DJ, Hilton, JD, Arnold, JM, Gregoire, J., Rivard, A. and Archer, SL (2006) Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: A phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther, 13, pp. 1503-1511.